Colony Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$928K Sell
13,398
-724
-5% -$50.1K 0.01% 440
2023
Q2
$1.33M Buy
14,122
+71
+0.5% +$6.7K 0.02% 395
2023
Q1
$1.16M Sell
14,051
-712
-5% -$58.9K 0.02% 415
2022
Q4
$1.1M Sell
14,763
-302
-2% -$22.5K 0.02% 466
2022
Q3
$1.25M Buy
15,065
+6,929
+85% +$573K 0.02% 399
2022
Q2
$774K Sell
8,136
-6,596
-45% -$627K 0.01% 514
2022
Q1
$1.73M Sell
14,732
-670
-4% -$78.9K 0.03% 377
2021
Q4
$2M Sell
15,402
-325
-2% -$42.1K 0.04% 325
2021
Q3
$1.78M Hold
15,727
0.03% 329
2021
Q2
$1.63M Buy
15,727
+594
+4% +$61.5K 0.03% 323
2021
Q1
$1.27M Sell
15,133
-97
-0.6% -$8.12K 0.03% 357
2020
Q4
$1.39M Buy
15,230
+323
+2% +$29.5K 0.03% 318
2020
Q3
$1.19M Hold
14,907
0.03% 335
2020
Q2
$1.03M Buy
14,907
+3,150
+27% +$218K 0.03% 339
2020
Q1
$739K Sell
11,757
-2,127
-15% -$134K 0.02% 388
2019
Q4
$1.08M Buy
13,884
+1,350
+11% +$105K 0.03% 393
2019
Q3
$919K Buy
12,534
+1,254
+11% +$91.9K 0.03% 386
2019
Q2
$695K Sell
11,280
-135,642
-92% -$8.36M 0.02% 438
2019
Q1
$9.37M Sell
146,922
-1,242
-0.8% -$79.2K 0.39% 72
2018
Q4
$7.57M Sell
148,164
-174
-0.1% -$8.88K 0.37% 82
2018
Q3
$8.61M Sell
148,338
-4,122
-3% -$239K 0.43% 63
2018
Q2
$7.4M Buy
152,460
+46,131
+43% +$2.24M 0.39% 71
2018
Q1
$4.95M Buy
+106,329
New +$4.95M 0.27% 92
2014
Q4
Sell
-348
Closed -$6K 785
2014
Q3
$6K Buy
348
+318
+1,060% +$5.48K ﹤0.01% 680
2014
Q2
$0 Buy
+30
New ﹤0.01% 785